The Tetraphase Pharmaceuticals Inc. shares had fallen in late trading Tuesday to 80%. This is after a study discovered that its manufactured experimental antibiotic was no better than a standard generic treatment.
Medical
British doctors on a 24-hour strike: Demands better pay and working hours
Protests turned into a full-fledged 24-hour strike by the junior doctors of NHS when their negotiations with the government failed to yield results. The new policy failed to address payment issues and overall job security.
Painkillers, Heroin increase US overdose cases
A powerful type of opioid painkillers and Heroin are the leading causes of drug overdose in the US, according to new federal statistics. Yahoo News reported that opioid painkillers have long been the leading reasons for overdose deaths in the US, but cases of death with heroin use have recently grown.
Generic Drug Sale widens in Japan as Takeda and Teva join hands
Teva pharmaceuticals which is said to be the world's largest generic drug maker has joined hands with Takeda Pharmaceutical Co, for a definitive agreement to sell generic drugs in Japan.
Express Scripts offers cheaper $1 pill alternative to Turing's $750 per pill drug
Drug prescription firm Express Scripts Holding Co. found a way to offer a cheaper $1 alternative to Turing’s $750 a pill drug.
Latest News
Pfizer Inc. has failed again in enforcing its intellectual property rights in India. The giant pharmaceutical's patent on its rheumatoid arthritis drug, Tofacitinib, was rejected in the country.
Valeant Pharmaceuticals, Inc. of Canada has partnered with AstraZeneca for the selling rights of psoriasis drug brodalumab. Amgen Inc. ended its partnership with AstraZeneca due to its worries over the drug's side effects.
A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.
GN Store Nord reported first-quarter core profit a touch below forecasts on Wednesday and its shares fell as its headset division disappointed despite a strong performance by the larger hearing aid segment.
Biogen Idec Inc has seen its market value quadruple in three years to more than $100 billion on the back of its successful multiple sclerosis drugs. Now it has new ambitions in its sights.
New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses.
China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from a year before, the official Center for Drug Evaluation said on Friday, reflecting industry concern that it is getting harder to get medicines approved in the China market.
AbbVie Inc (ABBV.N) is to buy Pharmacyclics Inc (PCYC.O) for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field.
In a smart building in an upscale neighborhood of Gaza City, Salah El-Zanin is seeing a growing number of clients. Trained in Greece, he is the only plastic surgeon in Gaza with European qualifications, and his business is booming.
